Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Aly

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
Acta Oncologica (Stockholm, Sweden)|May 25, 2011
Early detection of prostate cancer with emphasis on genetic markersMarkus Aly, Fredrik Wiklund, Henrik Grönberg
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 9, 2023
Association between early mobilisation after abdominal cancer surgery and postoperative complicationsAndrea Porserud, Markus Aly, Malin Nygren-Bonnier, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 30, 2019
Objectively measured mobilisation is enhanced by a new behaviour support tool in patients undergoing abdominal cancer surgeryAndrea Porserud, Markus Aly, Malin Nygren-Bonnier, et al.
Scandinavian Journal of Urology|December 18, 2024
Exercise in primary care after robot-assisted radical cystectomy for urinary bladder cancer - effects on postoperative complications: a secondary analysis of a randomised controlled trialAndrea Porserud, Markus Aly, Hanna Steinertz, et al.
Prostate Cancer and Prostatic Diseases|December 21, 2017
Prostate-specific antigen (PSA) density in the diagnostic algorithm of prostate cancerTobias Nordström, Olof Akre, Markus Aly, et al.
BJU International|June 30, 2021
The 90-day cause-specific mortality after radical prostatectomy: a nationwide population-based studyJohan Björklund, Pär Stattin, Erik Rönmark, et al.
European Urology|July 30, 2013
A genetic score can identify men at high risk for prostate cancer among men with prostate-specific antigen of 1-3 ng/mlTobias Nordström, Markus Aly, Martin Eklund, et al.
Pilot and Feasibility Studies|January 23, 2024
The feasibility of an exercise intervention after robotic-assisted radical cystectomy for urinary bladder cancer, prior to the CanMoRe trialAndrea Porserud, Patrik Karlsson, Malin Nygren-Bonnier, et al.
Pathology|September 5, 2024
Benign prostatic hyperplasia and insignificant prostate cancer with very high levels of serum prostate specific antigenHemamali Samaratunga, Brett Delahunt, Mats Olsson, et al.
BMJ Open|June 16, 2019
Does a novel diagnostic pathway including blood-based risk prediction and MRI-targeted biopsies outperform prostate cancer screening using prostate-specific antigen and systematic prostate biopsies? - protocol of the randomised study STHLM3MRITobias Nordström, Fredrik Jäderling, Stefan Carlsson, et al.
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
Acta Oncologica (Stockholm, Sweden)|May 25, 2011
Early detection of prostate cancer with emphasis on genetic markersMarkus Aly, Fredrik Wiklund, Henrik Grönberg
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 9, 2023
Association between early mobilisation after abdominal cancer surgery and postoperative complicationsAndrea Porserud, Markus Aly, Malin Nygren-Bonnier, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 30, 2019
Objectively measured mobilisation is enhanced by a new behaviour support tool in patients undergoing abdominal cancer surgeryAndrea Porserud, Markus Aly, Malin Nygren-Bonnier, et al.
Scandinavian Journal of Urology|December 18, 2024
Exercise in primary care after robot-assisted radical cystectomy for urinary bladder cancer - effects on postoperative complications: a secondary analysis of a randomised controlled trialAndrea Porserud, Markus Aly, Hanna Steinertz, et al.
Prostate Cancer and Prostatic Diseases|December 21, 2017
Prostate-specific antigen (PSA) density in the diagnostic algorithm of prostate cancerTobias Nordström, Olof Akre, Markus Aly, et al.
BJU International|June 30, 2021
The 90-day cause-specific mortality after radical prostatectomy: a nationwide population-based studyJohan Björklund, Pär Stattin, Erik Rönmark, et al.
European Urology|July 30, 2013
A genetic score can identify men at high risk for prostate cancer among men with prostate-specific antigen of 1-3 ng/mlTobias Nordström, Markus Aly, Martin Eklund, et al.
Pilot and Feasibility Studies|January 23, 2024
The feasibility of an exercise intervention after robotic-assisted radical cystectomy for urinary bladder cancer, prior to the CanMoRe trialAndrea Porserud, Patrik Karlsson, Malin Nygren-Bonnier, et al.
Pathology|September 5, 2024
Benign prostatic hyperplasia and insignificant prostate cancer with very high levels of serum prostate specific antigenHemamali Samaratunga, Brett Delahunt, Mats Olsson, et al.
BMJ Open|June 16, 2019
Does a novel diagnostic pathway including blood-based risk prediction and MRI-targeted biopsies outperform prostate cancer screening using prostate-specific antigen and systematic prostate biopsies? - protocol of the randomised study STHLM3MRITobias Nordström, Fredrik Jäderling, Stefan Carlsson, et al.
Pageof 9